logo
Plus   Neg
Share
Email

Sarepta Therapeutics Q3 adjusted earnings Beat Estimates

Below are the earnings highlights for Sarepta Therapeutics (SRPT):

-Earnings: -$126.33 million in Q3 vs. -$76.39 million in the same period last year.
-EPS: -$1.70 in Q3 vs. -$1.15 in the same period last year.
-Excluding items, Sarepta Therapeutics reported adjusted earnings of -$84.44 million or -$1.14 per share for the period.
-Analysts projected -$1.35 per share
-Revenue: $99.04 million in Q3 vs. $78.49 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT
>